4.25
Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
12.84%
6.963
|
7.989 | 9.261 | 6.251 | 7.401 |
Operating Income/Loss |
12.84%
-6.963
|
-7.989 | -9.261 | -6.251 | -7.401 |
Nonoperating Income/Loss |
93.97%
0.516
|
8.559 | -12.26 | 2.155 | 17.26 |
Income/Loss From Continuing Operations Before Tax |
1,231%
-6.447
|
0.57 | -21.52 | -4.096 | 9.855 |
Income/Loss From Continuing Operations After Tax |
1,231%
-6.447
|
0.57 | -21.52 | -4.096 | 9.855 |
|
1,231%
-6.447
|
0.57 | -21.52 | -4.096 | 9.855 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | 0.887 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
89.47%
12.30
|
116.82 | 12.91 | 88.94 | 37.91 |
Diluted Average Shares |
90.07%
12.30
|
123.83 | 12.91 | 88.94 | 94.05 |
Basic Earnings Per Share |
1,833%
-0.52
|
0.03 | -0.26 | -0.05 | 0.08 |
Diluted Earnings Per Share |
940.00%
-0.52
|
-0.05 | -0.26 | -0.05 | -0.15 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):